Revenio Group Oyj

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FI0009010912
EUR
22.15
0.6 (2.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Revenio Group Oyj stock-summary
stock-summary
Revenio Group Oyj
Pharmaceuticals & Biotechnology
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
Company Coordinates stock-summary
Company Details
Ayritie 22 , VANTAA None : 01510
stock-summary
Tel: 358 9 87751150
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Pekka Ronka
Independent Chairman of the Board
Mrs. Ann-Christine Sundell
Director
Mr. Kyosti Kakkonen
Independent Director
Mr. Ari Kohonen
Independent Director
Mr. Pekka Tammela
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Jun 2025)
Net Profit:
3 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 591 Million ()

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

16.97%

stock-summary
Price to Book

5.42